Stockreport

Yield10 Bioscience Signs Research License Agreement Covering CRISPR-Cas9 Genome-Editing Technology with the Broad Institute and Pioneer

Yield10 Bioscience, Inc.  (YTEN) 
US:NASDAQ Investor Relations: ir.yield10bio.com/investor-relations
PDF WOBURN, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in cr [Read more]